Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

Technology Scientific & Technical Instruments
SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

SQI Diagnostics Inc > High Profile Involvement.... time to shine SQI.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(737)
•••
Comment by mercedesmanon Jul 24, 2021 9:20am
106 Views
Post# 33600637

RE:RE:RE:RE:RE:High Profile Involvement.... time to shine SQI.

RE:RE:RE:RE:RE:High Profile Involvement.... time to shine SQI.

Thx Cleareye 

I agree totally. 

while the Rali-DX is likely a short term timeline set-back, the big opportunity ( antibody testing) is still in play ...

Re: the Anti-body Home-test. The new partner will not treat it simply as a Home test but will offer it through their network of corporate and other clients. 

this is the big opportunity. The $3B one !

unfortunately the US and therefor the FDA is still bogged down with an under-vaccinated population and therefor must prioritize therapeutics, equipment and basic testing. 

the next phase (are the vaccination administered still effective, and for how long?) is still coming down the road. The FDA knows that. 

I will continue to hold and probably add if I see any more weakness. 


MM 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities